发明名称 |
Treatment of B-cell malignancies |
摘要 |
<p>The present invention generally relates to a pharmaceutical composition and to an improved method of preventing, attenuating and treating multiple myeloma by administering to an individual in need thereof at least one antibody to fibroblast growth factor receptor 3 (FGFR3). In particular, the at least one FGR3 antibody induces apoptosis of myeloma cells expressing wild type FGFR3.</p> |
申请公布号 |
AU2005302083(A1) |
申请公布日期 |
2006.05.11 |
申请号 |
AU20050302083 |
申请日期 |
2005.11.03 |
申请人 |
FIBRON LIMITED;UNIVERSITY HEALTH NETWORK |
发明人 |
ERAN ROM;AVNER YAYON;SUZANNE TRUDEL |
分类号 |
A61K39/395 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|